Outcomes of Metastatic and Unresectable Small Bowel Adenocarcinoma in Japan According to the Treatment Strategy: A Nationwide Observational Study.
Yoshitaka NishikawaTakahiro HorimatsuShiro OkaTakeshi YamadaKeigo MitsuiHironori YamamotoKeiichi TakahashiAkio ShiomiKinichi HottaToshio UraokaToshio KuwaiFumio IshidaShin-Ei KudoShoichi SaitoMasashi UenoEiji SunamiTomoki YamanoMichio ItabashiKazuo OhtsukaYusuke KinugasaTakayuki MatsumotoTamotsu SugaiMasashi NamikawaKoichi KuraharaShigeki YamaguchiTomohiro KatoMasazumi OkajimaHiroshi KashidaFumihiko FujitaHiroaki IkematsuMasaaki ItoMotohiro EsakiMasaya KawaiTakashi YaoMadoka HamadaKeiji KodaYasumori FukaiKoji KomoriYusuke SaitohYukihide KanemitsuHiroyuki TakamaruKazutaka YamadaHiroaki NozawaTetsuji TakayamaKazutomo TogashiEiji ShintoTakehiro TorisuAkira ToyoshimaNaoki OhmiyaTakeshi KatoEigo OtsujiShinji NagataYojiro HashiguchiKenichi SugiharaYoichi AjiokaShinji TanakaPublished in: JCO global oncology (2024)
Patients treated with surgery, chemotherapy, or both had a better prognosis than those who received best supportive care. Among patients who received chemotherapy, survival did not differ according to the chemotherapeutic regimen.
Keyphrases
- locally advanced
- small bowel
- squamous cell carcinoma
- rectal cancer
- minimally invasive
- radiation therapy
- healthcare
- small cell lung cancer
- palliative care
- coronary artery bypass
- cross sectional
- metabolic syndrome
- adipose tissue
- surgical site infection
- free survival
- affordable care act
- liver metastases
- chronic pain
- coronary artery disease
- health insurance
- insulin resistance